Despite a notable decline in Tenaris’s future P/E ratio, indicating improved value or lower growth expectations, the consensus analyst price target remained unchanged at €17.58.
What's in the News
- Tenaris completed the repurchase of 109,475,548 shares (9.64%) for $1,888.9 million under its previous buyback program.
- From June 9 to June 30, 2025, Tenaris repurchased 13,094,268 shares (1.22%) for $237 million under a new buyback program.
- Tenaris launched a new share repurchase program, authorized to buy back up to 10% of issued share capital, with a total allocation of $1,200 million, to be completed within a year.
- The first tranche of the new buyback involves a non-discretionary agreement with a financial institution to repurchase up to $600 million worth of shares by December 8, 2025; repurchased shares will be cancelled.
Valuation Changes
Summary of Valuation Changes for Tenaris
- The Consensus Analyst Price Target remained effectively unchanged, at €17.58.
- The Future P/E for Tenaris has significantly fallen from 12.56x to 10.94x.
- The Discount Rate for Tenaris remained effectively unchanged, moving only marginally from 6.82% to 6.81%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.